Kontoor Brands Earnings Call: Key Takeaways
Kontoor Brands completed the Lee divestiture, shifting focus to Wrangler and Heli Hansen while raising EPS guidance despite moderating retail POS trends and inventory caution.
- Call
- Nov 5, 2026, 8:30 AM ET
ALFA USA Filings
Every alert, straight from SEC EDGAR
Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Filing type
Alerts
Time
22,609 alerts with these filters
Kontoor Brands completed the Lee divestiture, shifting focus to Wrangler and Heli Hansen while raising EPS guidance despite moderating retail POS trends and inventory caution.
BGSF reported a 6.6% revenue decline amid soft multi-family demand, responding with a $1.6 million annualized cost restructuring to protect margins.
Ralph Lauren Corporation reported net revenues of $2.19 billion for the quarter ended September 26, 2026, a 9% increase over the prior year. Net income rose to $296.6 million, driven by higher gross profit margins and strong operating performance despite increased restructuring charges.
USA TODAY Co. reported a net loss of $4.6 million for the third quarter of 2026, though it maintained a net income of $24.4 million for the first nine months of the year. Total revenues declined year-over-year for both the three and nine-month periods, primarily driven by a decrease in print and commercial revenue.
For the third quarter of 2026, Kontoor Brands reported net revenues of $685.3 million, a slight increase from $666.5 million in the prior year, though it swung to a net loss of $29.5 million due to a significant $102.7 million income tax expense. For the nine months ended September 2026, the company maintained a net income of $127.7 million, supported by strong operating income of $257.7 million.
Arrow Electronics delivered record Q3 results with $10.7 billion revenue and $6.22 EPS, driven by AI infrastructure demand and significant operating leverage despite inventory builds and extending lead times.
Core Scientific is successfully transitioning to a pure-play AI infrastructure provider, leveraging massive contracts with CoreWeave and AMD to drive significant sequential revenue and EBITDA growth despite regulatory and financing headwinds.
NorthWestern Energy reported Q3 2026 net income of $30.7 million, or $0.50 per diluted share, down from $0.62 in the prior year due to costs from increased ownership in Colstrip Units 3 and 4. The company reaffirmed its full-year 2026 earnings guidance of $3.68 to $3.83 per share and expects its merger with Black Hills to close by year-end 2026.
“The third quarter was a busy and productive one for NorthWestern. We continued to execute on our core business and remain focused on delivering long-term value for our customers, communities, and shareholders. Although the costs associated with our incremental ownership in Colstrip have created a temporary earnings headwind, this strategic decision helps ensure reliable energy for our customers and support economic development in Montana.”
Brian Bird, President and CEO
Phibro delivered 6% revenue growth and 11% net income growth in Q1, maintaining FY2027 guidance despite margin pressure in animal health and regulatory delays in Brazil.
The Federal Home Loan Bank of Dallas committed to the issuance of $10 million in consolidated obligation bonds. These debt securities are joint and several obligations of the 11 Federal Home Loan Banks and are sold through the Office of Finance to fund the Bank's operations. The specific bond has a fixed coupon rate of 5.050% and matures on November 17, 2031.
Iovance delivered record Q3 revenue of $122 million and 60% margins, driven by strong Amtagvi adoption and a cash runway extended into 2029.
Perimeter Group Inc. reported a significant increase in net sales to $728.7 million for the first nine months of 2026, up from $550.1 million in the prior year. The company swung to a net income of $195.8 million for the nine-month period, largely driven by a favorable $49.6 million change in the fair value of founders advisory fees compared to a $264.0 million expense in 2025.
BlackSky delivered record Q3 2026 results with 118% revenue growth, positive operating cash flow, and a second guidance raise driven by Gen 3 satellite adoption and a $1 billion international AI space infrastructure win.
GPGI delivered mixed Q3 results with strong performance at CompoSecure offset by execution delays and macro headwinds at Husky, leading to a lowered full-year EBITDA guidance despite improving demand signals.
Prospect Capital reported NII of $0.15 per share and NAV of $5.36, emphasizing a shift toward first-lien senior secured loans and a significant reduction in PIK income.
Frontdoor delivered strong Q3 results, raising full-year EBITDA guidance despite record heat-driven claims costs, while aggressively returning capital through a new $1 billion share repurchase authorization.
Chimera faced a challenging Q3 2026 with a 16.5% book value decline due to rate volatility, though investment portfolio EAD remained resilient at $0.38 per share.
For the nine months ended September 30, 2026, ACI Worldwide reported total revenues of $1.28 billion, remaining relatively flat compared to the prior year, while net income decreased from $162.3 million to $102.6 million. The company experienced a significant decline in license revenue and an increase in operating expenses, particularly in research and development and general and administrative costs.
Agios Pharmaceuticals reported a significant increase in product revenue to $55.4 million for Q3 2026, compared to $12.9 million in Q3 2025. Despite the revenue growth, the company recorded a net loss of $65.0 million for the quarter and $264.9 million for the first nine months of 2026, driven by high research and development and SG&A expenses.
Diversified Energy is executing a 'buy-finance-optimize' model, leveraging the Birch acquisition to double free cash flow while maintaining a 17% shareholder return yield despite natural gas price volatility.
Lipocine Inc. reported financial results for the third quarter of 2026, highlighting a net loss of $0.7 million and a cash position of $21.5 million as of September 30, 2026. The company also provided clinical updates, including the initiation of the Phase 3 BLOOM study for LPCN 1154 (BRLIZIO) in postpartum depression and the approval of TLANDO in Canada.
Rajesh Magow, Group CEO, sold 30,000 shares of MakeMyTrip Ltd at $45.25 to $50.11 a share (average $46.87) in 2 transactions, worth $1.41M in total between Nov 3, 2026 and Nov 4, 2026. Shares held after the trade: 0 (-100.0%).
Haemonetics delivered strong Q2 results with 10% organic revenue growth, raising full-year guidance driven by a major CSL relationship expansion and Persona Plus adoption despite near-term margin pressure from growth investments.
Coastal Financial Corporation reported total assets of $5.28 billion as of September 30, 2026, an increase from $4.74 billion at year-end 2025, driven by growth in loans receivable and interest-earning deposits. However, total shareholders' equity decreased slightly to $478.3 million from $491.0 million, primarily due to a reduction in retained earnings.
Lipocine Inc. reported total revenues of $2.6 million for the nine months ended September 30, 2026, driven by a $2.1 million license fee. Despite the revenue increase, the company incurred a net loss of $7.0 million due to higher operating expenses, though it maintains sufficient capital to fund operations through November 2027.
Bob's Discount Furniture delivered a strong Q3 with 10.3% revenue growth and 3.8% comps, successfully navigating fuel headwinds through SG&A leverage and premium product mix shift despite gross margin pressure.
MSC Income Fund's Board of Directors declared regular monthly cash dividends of $0.11 per share for January, February, and March 2027, totaling $0.33 for the first quarter. Additionally, the Fund declared a supplemental cash dividend of $0.03 per share payable in March 2027, sourced from undistributed taxable income as of September 30, 2026.
Xeris Biopharma delivered a strong Q3 with 44% revenue growth, significantly raising 2030 revenue targets to over $1 billion driven by Recorlev momentum.
Viatris Inc. reported its third quarter 2026 results, highlighting the completion of its OTC business divestiture and the pending acquisition of Pacira BioSciences for $36.50 per share. The company continues to operate through four segments: Developed Markets, Emerging Markets, JANZ, and Greater China, following its 2020 formation via the combination of Mylan and Pfizer's Upjohn business.
Enhanced Group Inc. has entered into definitive exchange agreements to acquire an approximately 77% controlling interest in DEAG Deutsche Entertainment AG, a Berlin-headquartered live entertainment and ticketing platform. The all-stock transaction involves the issuance of approximately 11 million shares of Class A common stock at a value of $8 per share, complemented by a concurrent $15 million PIPE investment to fund growth and operations.
“I believe one of the most significant long-term consequences of AI and robotics will be a gradual reduction in the need for human labor. And I believe people will mostly allocate this free time to shared, real live human experiences. This creates scarcity, as sports and live experiences cannot be automated or replicated by AI. A live game, a concert, a record broken in front of a crowd - all those moments create goosebumps and become more valuable as everything else becomes digitally abundant. We believe the winners will be the companies that own the content, the stage and the ticket. With DEAG, Enhanced will have all three: owned sports and live IP, a broad promoter and venue network, and proprietary ticketing. And we believe we are acquiring it at a very attractive valuation.”
Maximilian Martin, Co-Founder and Chief Executive Officer of Enhanced